Overview
- 28 inspections across 27 sites are on record.
- 86 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-05-08.
At a glance
Inspections
28
Sites
27
Observations
86
Career since
Aug 2021
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| VA San Diego Healthcare Systems | 8 May 2026 | Human Drugs | On file |
| Molecular Imaging Program at Stanford | 17 Apr 2026 | Human Drugs | View 483 → |
| Spectrum Laboratory Products, Inc. | 20 Mar 2026 | Human Drugs | On file |
| Pharmalogic Salt Lake City, LLC | 24 Feb 2026 | Human Drugs | View 483 → |
| SPI Pharma, Inc. | 26 Sep 2025 | Human Drugs |
Sites inspected
VA San Diego Healthcare SystemsSan Diego, United States1 insp.
Molecular Imaging Program at StanfordPalo Alto, United States1 insp.
Spectrum Laboratory Products, Inc.Gardena, United States1 insp.
Pharmalogic Salt Lake City, LLCSalt Lake City, United States1 insp.
SPI Pharma, Inc.Grand Haven, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Gunneet Kaur4 shared
Lillian S Wu2 shared
Cecilia H Kieu2 shared
Jolanna A Norton2 shared
Dustin M James2 shared
Dogbeda F Mackenzie2 shared
Jeffrey P Raimondi2 shared
Sateesh Kum Sathigari1 shared
Zachary L Stamm1 shared
Joey V Quitania1 shared
Full investigator report
Get the verbatim findings behind Matthew R Clabeaux's 86 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site